Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ponchio, L
Right arrow Articles by Eaves, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponchio, L
Right arrow Articles by Eaves, C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro

L Ponchio, E Conneally and C Eaves

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada.

A method for quantitating the proportion of cycling long-term culture- initiating cells (LTC-IC) in heterogeneous populations of human hematopoietic cells is described. This procedure involves incubating the cells of interest for 16 to 24 hours in a serum-free medium containing 100 ng/mL Steel factor (SF), 20 ng/mL interleukin-3 (IL-3), and 20 ng/mL granulocyte-colony-stimulating factor (G-CSF), with or without 20 microCi/mL of high specific activity 3H-thymidine (3H-Tdr) before plating the recovered cells in standard LTC-IC assays. The details of this procedure are based in part on the finding that the number of LTC-IC (regardless of their cycling status) remains constant for at least 24 hours under these culture conditions, as long as 3H-Tdr is not present. In addition, we have determined that a 16-hour period of exposure to the 3H-Tdr is sufficient to maximize the discrimination of cycling LTC-IC but not long enough to allow a detectable redistribution of LTC-IC between noncycling and cycling compartments. Finally, any isotope reutilization that may occur is not sufficient to affect the LTC-IC 3H-Tdr suicide values measured. Application of this methodology to normally circulating LTC-IC showed these to be a primarily quiescent population. However, within 72 hours of incubation in a serum-free medium containing SF, IL-3, and G-CSF, most had entered S-phase, although there was no net change in their numbers. This suggests that, under certain conditions in vitro, self-renewal divisions of LTC-IC can occur and, at least initially, balance any losses of these cells due to their differentiation or death. In contrast, many of the LTC-IC in freshly aspirated samples of normal marrow were found to be proliferating, although those that were initially quiescent could also be recruited into S-phase within 72 hours in vitro when incubated under the same conditions used to stimulate circulating LTC-IC. This modified 3H-Tdr suicide procedure should facilitate further investigation of the mechanisms regulating the turnover of the most primitive compartments of human hematopoietic cells and how these may be altered in disease states or exploited for a variety of therapeutic applications.

Volume 86, Issue 9, pp. 3314-3321, 11/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
I. Dybedal, L. Yang, D. Bryder, I. Aastrand-Grundstrom, K. Leandersson, and S. E. W. Jacobsen
Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
Blood, July 1, 2003; 102(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Guan, B. Gerhard, and D. E. Hogge
Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)
Blood, April 15, 2003; 101(8): 3142 - 3149.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Cashman, B. Dykstra, I. Clark-Lewis, A. Eaves, and C. Eaves
Changes in the Proliferative Activity of Human Hematopoietic Stem Cells in NOD/SCID Mice and Enhancement of Their Transplantability after In Vivo Treatment with Cell Cycle Inhibitors
J. Exp. Med., November 4, 2002; 196(9): 1141 - 1150.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Cashman, I. Clark-Lewis, A. Eaves, and C. Eaves
Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice
Blood, February 1, 2002; 99(3): 792 - 799.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. E. Wright, S. H. Cheshier, A. J. Wagers, T. D. Randall, J. L. Christensen, and I. L. Weissman
Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle
Blood, April 15, 2001; 97(8): 2278 - 2285.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Bennaceur-Griscelli, C. Pondarre, V. Schiavon, W. Vainchenker, and L. Coulombel
Stromal cells retard the differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history
Blood, January 15, 2001; 97(2): 435 - 441.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. W. Stacey, M. Hitomi, and G. Chen
Influence of Cell Cycle and Oncogene Activity upon Topoisomerase IIalpha Expression and Drug Toxicity
Mol. Cell. Biol., December 15, 2000; 20(24): 9127 - 9137.
[Abstract] [Full Text]


Home page
BloodHome page
H. Glimm, I.-H. Oh, and C. J. Eaves
Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0
Blood, December 15, 2000; 96(13): 4185 - 4193.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. F. Srour;, C. Eaves, and H. Glimm
Proliferative history and hematopoietic function of ex vivo expanded human CD34+ cells
Blood, August 15, 2000; 96(4): 1609 - 1612.
[Full Text] [PDF]


Home page
BloodHome page
F. Liu, J. Poursine-Laurent, and D. C. Link
Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF
Blood, May 15, 2000; 95(10): 3025 - 3031.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. J. Oostendorp, J. Audet, and C. J. Eaves
High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo
Blood, February 1, 2000; 95(3): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.D. Cashman, I. Clark-Lewis, A.C. Eaves, and C.J. Eaves
Differentiation Stage-Specific Regulation of Primitive Human Hematopoietic Progenitor Cycling by Exogenous and Endogenous Inhibitors in an In Vivo Model
Blood, December 1, 1999; 94(11): 3722 - 3729.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Huang, P. Law, K. Francis, B. O. Palsson, and A. D. Ho
Symmetry of Initial Cell Divisions Among Primitive Hematopoietic Progenitors Is Independent of Ontogenic Age and Regulatory Molecules
Blood, October 15, 1999; 94(8): 2595 - 2604.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Glimm and C.J. Eaves
Direct Evidence for Multiple Self-Renewal Divisions of Human In Vivo Repopulating Hematopoietic Cells in Short-Term Culture
Blood, October 1, 1999; 94(7): 2161 - 2168.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Holyoake, X. Jiang, C. Eaves, and A. Eaves
Isolation of a Highly Quiescent Subpopulation of Primitive Leukemic Cells in Chronic Myeloid Leukemia
Blood, September 15, 1999; 94(6): 2056 - 2064.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Bennaceur-Griscelli, C. Tourino, B. Izac, W. Vainchenker, and L. Coulombel
Murine Stromal Cells Counteract the Loss of Long-Term Culture-Initiating Cell Potential Induced by Cytokines in CD34+CD38low/neg Human Bone Marrow Cells
Blood, July 15, 1999; 94(2): 529 - 538.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. R. Beauchamp, J. E. Morgan, C. N. Pagel, and T. A. Partridge
Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell-like Properties as the Myogenic Source
J. Cell Biol., March 22, 1999; 144(6): 1113 - 1122.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. B. van Hennik, M. M.A. Verstegen, M. F.A. Bierhuizen, A. Limon, A. W. Wognum, J. A. Cancelas, J. Barquinero, R. E. Ploemacher, and G. Wagemaker
Highly Efficient Transduction of the Green Fluorescent Protein Gene in Human Umbilical Cord Blood Stem Cells Capable of Cobblestone Formation in Long-Term Cultures and Multilineage Engraftment of Immunodeficient Mice
Blood, December 1, 1998; 92(11): 4013 - 4022.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Dao, N. Taylor, and J. A. Nolta
Reduction in levels of the cyclin-dependent kinase inhibitor p27kip-1 coupled with transforming growth factor beta  neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
PNAS, October 27, 1998; 95(22): 13006 - 13011.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Haurie, D. C. Dale, and M. C. Mackey
Cyclical Neutropenia and Other Periodic Hematological Disorders: A Review of Mechanisms and Mathematical Models
Blood, October 15, 1998; 92(8): 2629 - 2640.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Gothot, R. Pyatt, J. McMahel, S. Rice, and E. F. Srour
Functional Heterogeneity of Human CD34+ Cells Isolated in Subcompartments of the G0 /G1 Phase of the Cell Cycle
Blood, December 1, 1997; 90(11): 4384 - 4393.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Humeau, C. Chabannon, M. T. Firpo, P. Mannoni, C. Bagnis, M.-G. Roncarolo, and R. Namikawa
Successful Reconstitution of Human Hematopoiesis in the SCID-hu Mouse by Genetically Modified, Highly Enriched Progenitors Isolated From Fetal Liver
Blood, November 1, 1997; 90(9): 3496 - 3506.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Liu, J. Poursine-Laurent, and D. C. Link
The Granulocyte Colony-Stimulating Factor Receptor Is Required for the Mobilization of Murine Hematopoietic Progenitors Into Peripheral Blood by Cyclophosphamide or Interleukin-8 But Not Flt-3 Ligand
Blood, October 1, 1997; 90(7): 2522 - 2528.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A.L. Petzer, C.J. Eaves, M.J. Barnett, and A.C. Eaves
Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia
Blood, July 1, 1997; 90(1): 64 - 69.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. D. Williams, D. C. Linch, M. J. Watts, and N. S. B. Thomas
Characterization of Cell Cycle Status and E2F Complexes in Mobilized CD34+ Cells Before and After Cytokine Stimulation
Blood, July 1, 1997; 90(1): 194 - 203.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. M. Lemoli, A. Tafuri, A. Fortuna, M. T. Petrucci, M. R. Ricciardi, L. Catani, D. Rondelli, M. Fogli, G. Leopardi, C. Ariola, et al.
Cycling Status of CD34+ Cells Mobilized Into Peripheral Blood of Healthy Donors by Recombinant Human Granulocyte Colony-Stimulating Factor
Blood, February 15, 1997; 89(4): 1189 - 1196.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020